Nicholas R. Deprez
Research Subjects
Nicholas R. Deprez has a total of 140 co-authors. Here are the top co-authors by number of shared publications:
- Justin A. Newman
Pharmaceutical Analysis & Digital Technologies, Merck & Company, Inc., 126 East Lincoln Avenue, Rahway, New Jersey 07065, United States
4 shared publications Clara Hartmanshenn
Department of Process Research and Development
3 shared publications- Nastaran Salehi Marzijarani
Process Research and Development, Merck & Co., Inc
3 shared publications - Ryan D. Cohen
Analytical Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
3 shared publications Stasik Popov
Process Research and Development, Merck & Co., Inc
3 shared publicationsSteve Castro
Process Research and Development, Merck & Co., Inc
3 shared publications
Latest Publications
- 25 March 2026
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 28 (13) , 4208-4213
Noncanonical β-Amino Esters and Amides via Direct Asymmetric Reductive Amination of α,α-Disubstituted β-Ketoesters and Amides
A direct asymmetric reductive amination (DARA) of α,α-disubstituted β-amino esters and amides has been developed to access a key β-amino amide intermediate for the commercial synthesis of a COVID protease inhibitor. High-throughput experimentation was utilized to identify a commercial ruthenium BINAP complex as an optimal catalyst for this transformation and counterion effects were critical for enabling the chemoselective reduction in this DARA strategy. The protocol was employed to synthesize a variety of highly substituted noncanonical β-amino esters and amides in good yields and excellent enantioselectivities. An intermolecular functional group tolerance study revealed that many Lewis basic functionalities are tolerated under reaction conditions and mechanistic insight was gained from reaction profile monitoring, isotopic labeling experiments, precatalyst poisoning studies, and ketone/imine equilibrium experiments.
- 25 March 2026
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 28 (13) , 4208-4213
Noncanonical β-Amino Esters and Amides via Direct Asymmetric Reductive Amination of α,α-Disubstituted β-Ketoesters and Amides
A direct asymmetric reductive amination (DARA) of α,α-disubstituted β-amino esters and amides has been developed to access a key β-amino amide intermediate for the commercial synthesis of a COVID protease inhibitor. High-throughput experimentation was utilized to identify a commercial ruthenium BINAP complex as an optimal catalyst for this transformation and counterion effects were critical for enabling the chemoselective reduction in this DARA strategy. The protocol was employed to synthesize a variety of highly substituted noncanonical β-amino esters and amides in good yields and excellent enantioselectivities. An intermolecular functional group tolerance study revealed that many Lewis basic functionalities are tolerated under reaction conditions and mechanistic insight was gained from reaction profile monitoring, isotopic labeling experiments, precatalyst poisoning studies, and ketone/imine equilibrium experiments.
- 30 October 2025
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 27 (45) , 12505-12511
Asymmetric Synthesis of MK-7845, an Investigational Treatment for COVID-19
An enantioselective seven-step synthesis of MK-7845, an investigational protease inhibitor for the treatment of COVID-19 is described. Key features of the synthesis include the preparation of a chiral isonitrile intermediate utilizing an asymmetric ruthenium-catalyzed reductive amination reaction to set the key amine stereocenter; a highly enantioselective, biocatalytic oxidation reaction with a monoamine oxidase enzyme to furnish a bicyclic imine; and, finally, the union of these fragments via a diastereoselective three-component Joullié-Ugi coupling reaction en route to MK-7845.
- 30 October 2025
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 27 (45) , 12505-12511
Asymmetric Synthesis of MK-7845, an Investigational Treatment for COVID-19
An enantioselective seven-step synthesis of MK-7845, an investigational protease inhibitor for the treatment of COVID-19 is described. Key features of the synthesis include the preparation of a chiral isonitrile intermediate utilizing an asymmetric ruthenium-catalyzed reductive amination reaction to set the key amine stereocenter; a highly enantioselective, biocatalytic oxidation reaction with a monoamine oxidase enzyme to furnish a bicyclic imine; and, finally, the union of these fragments via a diastereoselective three-component Joullié-Ugi coupling reaction en route to MK-7845.
- Top Cited Papers
- 24 March 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (13) , 11036-11048
Total Synthesis of Enlicitide Decanoate
We report the total synthesis of enlicitide decanoate, an orally bioavailable inhibitor of proprotein convertase subtilisin/kexin type 9 that is being developed for the treatment of atherosclerotic cardiovascular disease. It is a highly complex macrocyclic peptide with a significant number of nonpeptide structural elements that presents a daunting synthetic chemistry challenge. We describe the development of a convergent, efficient, and robust manufacturing process that enables the large-scale production of enlicitide.
- 24 March 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (13) , 11036-11048
Top Cited PapersTotal Synthesis of Enlicitide Decanoate
We report the total synthesis of enlicitide decanoate, an orally bioavailable inhibitor of proprotein convertase subtilisin/kexin type 9 that is being developed for the treatment of atherosclerotic cardiovascular disease. It is a highly complex macrocyclic peptide with a significant number of nonpeptide structural elements that presents a daunting synthetic chemistry challenge. We describe the development of a convergent, efficient, and robust manufacturing process that enables the large-scale production of enlicitide.
- 6 June 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (6) , 2157-2167
Rapid End-Game Process Development and First GMP Production of MK-7845: An Experimental Antiviral Treatment for COVID-19
- 6 June 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (6) , 2157-2167
Rapid End-Game Process Development and First GMP Production of MK-7845: An Experimental Antiviral Treatment for COVID-19
- 24 October 2023
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 27 (11) , 1965-1974
Manufacturing Process Development for the Biaryl Ether Fragment of Nemtabrutinib (MK-1026)
- 24 October 2023
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 27 (11) , 1965-1974
Manufacturing Process Development for the Biaryl Ether Fragment of Nemtabrutinib (MK-1026)
- 13 October 2023
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 27 (11) , 1954-1964
Vision-Guided Automation Platform for Liquid–Liquid Extraction and Workup Development
- 13 October 2023
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 27 (11) , 1954-1964
Vision-Guided Automation Platform for Liquid–Liquid Extraction and Workup Development
- 3 November 2021
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 23 (22) , 8834-8837
Selective Electrochemical Oxidation of Functionalized Pyrrolidines
A method for the selective electrochemical aminoxyl-mediated Shono-type oxidation of pyrrolidines to pyrrolidinones is described. These transformations show the high selectivity and functional group compatibility. This chemistry also demonstrates the use of an operationally simple ElectraSyn 2.0 and cost-effective stainless-steel electrode for the electrochemical oxidation of functionalized pyrrolidines.
- 3 November 2021
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 23 (22) , 8834-8837
Selective Electrochemical Oxidation of Functionalized Pyrrolidines
A method for the selective electrochemical aminoxyl-mediated Shono-type oxidation of pyrrolidines to pyrrolidinones is described. These transformations show the high selectivity and functional group compatibility. This chemistry also demonstrates the use of an operationally simple ElectraSyn 2.0 and cost-effective stainless-steel electrode for the electrochemical oxidation of functionalized pyrrolidines.